Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01496092Phase 3Completed
A Phase 3 trial of Ketosteril in insulin resistance (IR), sponsored by Peking University First Hospital. Started Apr 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01496092.